EVAX – evaxion biotech a/s - american depositary share (US:NASDAQ)
Stock Stats
News
Evaxion announces business update and full year 2025 financial results
Evaxion plans to file 2025 annual report later today
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
Evaxion A/S (NASDAQ:EVAX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Form 6-K Evaxion A/S For: Mar 05
Form 20-F Evaxion A/S For: Dec 31
Form 6-K Evaxion A/S For: Mar 05
Form 6-K Evaxion A/S For: Mar 02
Form 6-K Evaxion A/S For: Feb 27
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.